Research To Practice | Oncology Videos

Latest Episodes:

Small Cell Lung Cancer | Jacob Sands, MD Jun 09, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Small Cell Lung Cancer | Faculty Presentation 1: Limited-Stage Small Cell Lung Cancer (SCLC); First-Line and Maintenance Therapy for Extensive-Stage SCLC — Jacob Sands, MD

CME information and select publications

Small Cell Lung Cancer | Christine L Hann, MD, PhD Jun 08, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Small Cell Lung Cancer | Faculty Presentation 2: Management of Relapsed/Refractory SCLC; Promising Investigational Agents and Strategies — Christine L Hann, MD, PhD

CME information and select publications

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays Jun 05, 2026

Show notes

Featuring perspectives from Prof Thomas Powles, including the following topics:

Circulating tumor DNA (ctDNA) analyses with adjuvant nivolumab for MIBC in the CheckMate 274 study (0:00)
Use of ctDNA to guide response-adapted bladder preservation for patients with MIBC (2:27)
ctDNA response-adapted treatment de-escalation for patients with metastatic urothelial carcinoma: The CT-READ trial (10:26)
Emerging data and studies regarding urinary tumor DNA (18:04)

CME information and select publications

Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer Jun 03, 2026

Show notes

Featuring perspectives from Prof Ramez Eskander and Dr Bradley Monk, moderated by Dr Kathleen Moore, including the following topics:

Introduction (0:00)
Advances in Human Cadherin-6-Targeted Antibody-Drug Conjugates (ADCs) in Ovarian and Other Gynecologic Cancers — Dr Moore (1:30)
Leveraging TROP2-Directed ADCs in Advanced Gynecologic Cancers — Prof Eskander (35:39)
Tolerability and Other Practical Considerations with Novel Investigational ADCs in Advanced Gynecologic Cancers — Dr Monk (1:04:58)

CME information and select publications

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper Jun 02, 2026

Show notes

Interview conducted with Prof Bernd Kasper on March 5, 2026, by Dr Neil Love, including the following topics:

Current management of desmoid tumors: A review from the Desmoid Tumor Working Group (0:00)
Long-term nirogacestat treatment in adult patients with desmoid tumors: Updated efficacy and safety from the Phase III DeFi trial (8:26)
Phase IV trial of nirogacestat in adult premenopausal women with desmoid tumors (17:35)

CME information and select publications here.

Colorectal Cancer — Year in Review Series on Relevant New Datasets and Advances May 28, 2026

Show notes

Proceedings from a webinar on April 16, 2026, moderated by Dr Neil Love, including the following topics:

Introduction: Research To Practice Paper of the Year! (0:00)
Checkpoint Inhibitors for Localized Microsatellite Instability-High Tumors (11:12)
Circulating Tumor DNA Assays (21:58)
Checkpoint Inhibitors for Metastatic Disease (38:32)

CME information and select publications

Colorectal Cancer | Arvind Dasari, MD, MS May 28, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 2: Optimizing the Care of Patients with Nonmetastatic Colorectal Cancer (CRC) — Arvind Dasari, MD, MS

CME information and select publications

Colorectal Cancer | Anwaar Saeed, MD May 28, 2026

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer | Faculty Presentation 1: Recent Advances in the Management of Metastatic CRC (mCRC) — Anwaar Saeed, MD

CME information and select publications

Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays May 27, 2026

Show notes

Interview conducted on March 11, 2026, by Dr Neil Love, including the following topics:

Circulating tumor DNA (ctDNA)-guided adjuvant therapy with atezolizumab for muscle-invasive bladder cancer (MIBC) (0:00)
Use of ctDNA in guiding systemic treatment selection for patients with urothelial bladder cancer (10:03)
ctDNA analyses with perioperative durvalumab for MIBC in the Phase III NIAGARA study (16:51)
New research advances in the monitoring and management of urothelial bladder cancer (22:21)

CME information and select publications

Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances May 24, 2026

Show notes

Proceedings from a webinar on March 11, 2026, moderated by Dr Neil Love, including the following topics: